Technology To Make Love Life Simple & Hasslefree

0

Written on Saturday, May 31, 2008 by Gemini

Dating is easy when you sign up for a membership in a dating site. With technology as fast and easy as it is, you can find the love or your life, or at least a solid friend, when you allow yourself to meet new people. Dating has never been easier and when you check out the services that are provided to you on this site, you will be able to increase your chances of meeting that special someone now.

Dating sites have changed Dating sites have changed. Now, more than ever, you can option to sign up without having to commit to a relationship. Many people are simply looking to meet someone that they can connect with, be it a romantic level or platonic. Get the information that you want when you are seeking the right person for you. On this dating site, you will gain the information that you need. Safety, efficiency, and privacy are all important when seeking the right kind of mate.

Dating online Increase your chances of meeting that special someone right now. Dating has never been easier and when you check out the services that are provided to you on this site, you will find that you are more than satisfied with the outcome. Get the information that will protect you and give you opportunities to date the right type of people for you. Get started today.

Posted in , , |

Technology Transfer Services Immortalized

0

Written on Thursday, May 29, 2008 by Gemini

In recent times, the world's leading technology universities are opting in for a different business model, for the sole need of survival. Earlier they were involved only in research & development, and were least focused on the business front. The things started changing when investors in these institutions reduced their investments and hence these R&D centers started looking concentrating on business as well. That's why you'll see many R&D institutes going out in the market selling their research. Many leading technology institutes are in this league. However, in my opinion, Yissum - the technology transfer services company of the Hebrew University of Jerusalem - is in the lead position through its highly appreciated university technology transfer programs. It is responsible for marketing the inventions and know-how generated by the University's renowned researchers and students.

It has expertise in diverse domain from nanotechnology to medicine and pharmaceuticals, agriculture and nutrition, water and environmental technologies to computer science to homeland security. Speaking in terms of numbers, Yissum has granted 400+ technology licenses and is responsible for commercializing products of over $1 billion in worldwide sales every year. Over the past 40 years, Yissum has churned out many popular products like Exelon, Doxil, Superior ceramic ink, UV pearls, Sumo - louse repellent, and Ram onion. There are many successful companies that are born at Yissum including Algen Biopharmaceuticals, Avian Tech, Ester Neurosciences, HumanEyes Technologies, and many more.

Yissum has won many patents (and many more are pending) on various technologies namely Single Image Dehazing, Prevention of Age-Related Retinal Deterioration, New Biosensor for Nerve Gases, Drought-Tolerant Trees, and Process for Producing Organic Ultra Thin Films. I am mesmerized by the wide array of their research in technology field - Improved Cache Performance with Reduced Energy Consumption; Compiler Aided Ticket Scheduling; Markov Model Application for DNA-Arrays and Gene Identification just to name a few. If you want to involve yourself in the world's leading technology institution and contribute to the award winning technologies / products, I recommend Yissum - a true technology transfer company.

Posted in , , , , , , , |

Now we have a biochip that can detect cancer before symptoms develop

0

Written on Sunday, May 11, 2008 by Gemini

Researchers at the US Department of Energy’s Argonne National Laboratory have developed a chip that can save lives by diagnosing certain cancers even before patients become symptomatic. A tumour – even in its earliest asymptomatic phases – can affect proteins that find their way into a patient’s circulatory system. These proteins trigger the immune system to kick into gear, producing antibodies that regulate which proteins belong, and which do not.


-- Picture: Argonne biologist Daniel Schabacker prepares to load a biochip onto a scanner. The biochip (below) contains grids of small wells or ‘dots’, each of which contains a protein, antibody or nucleic acid, which helps detect cancer. --

The new technology, known as a biochip, consists of a 1x1 cm array that comprises anywhere between several dozen and several hundred ‘dots’, or small drops. Each of these drops contains a unique chemical that will attach itself to particular proteins that could be cancer tell-tales. “Antibodies are the guardians of what goes on in the body,” said Tim Barder, president of US-based Eprogen, Inc, which has licensed Argonne’s biochip technology. “If a cancer cell produces aberrant proteins, then it’s likely that the patient will have an antibody profile that differs from that of a healthy person,” he added.

In their hunt for cancer indicators, Eprogen uses a process, which sorts thousands of different proteins from cancer cells by both their electrical charge and their hydrophobicity or “stickiness.” The process creates 960 separate protein fractions, which are then arranged in a single biochip containing 96-well grids. Scientists then probe the microarrays with known serum or plasma “auto-antibodies” produced by the immune systems of cancer patients.

By using cancer patients’ own auto-antibodies as a diagnostic tool, doctors could potentially tailor treatments based on their personal auto-antibody profile. What makes this technique unique is that scientists can use the actual expression of the patient’s disease as a means of obtaining new and better diagnostic information that doctors could use to understand and fight cancer better. Biochips have already shown promise in diagnostic medicine and are useful in rapidly and accurately detecting other diseases, said Argonne biologist Daniel Schabacker, who developed the technology.

Posted in , , |

Quick test for deadly disease - Chikungunya - developed by the Indians!

0

Written on Monday, November 12, 2007 by Gemini

Thiruvananthapuram: An outbreak of the chikungunya virus in Kerala has prompted researchers to develop a new diagnostic test to distinguish chikungunya from dengue viruses.

The kit works as early as the second day of symptoms, whereas conventional tests can only detect antibodies a week after infection.Distinguishing between the two diseases is difficult as both have initial symptoms of fever and joint pains, and both are spread by the Aedes aegypti mosquito.

The test uses polymerase chain reaction (PCR) methods that rapidly produce thousands of copies of a gene. It contains two sets of gene probes – one common to all four types of dengue, and another specific to chikungunya. This is the first test that detects dengue and chikungunya viruses at once, say scientists at the Rajiv Gandhi Centre for Biotechnology (RGCB).

The scientists tested 120 patients’ blood samples and accurately picked out four cases of dengue and the remaining chikungunya cases, says Easwaran Sreekumar, a researcher at RGCB’s Department of Molecular Microbiology.

Posted in , |

Researchers find why donated blood goes bad!

0

Written on Wednesday, October 10, 2007 by Gemini

Chicago: Donated blood quickly loses some of its life-saving properties as an important gas dissipates, US researchers said on Monday, in a finding that explains why many patients fare poorly after blood transfusions.

Researchers at Duke University Medical Centre found that nitric oxide in red blood cells is key to transferring oxygen in the blood to tissues. This gas appears to break down almost immediately after red blood cells leave the body, leaving much of the blood stored in blood banks impaired, said Duke’s Dr Jonathan Stamler in the Proceedings of the National Academy of Sciences.

“If you don’t have nitric oxide in there, you can’t get oxygen into the tissues,” he said. But if you restore this gas, banked blood appears to regain this ability, Stamler said. “The medical community, for the past few years, has been struggling with this issue of blood not being quite as good as we’d hoped,” he said.

He noted that many studies have shown patients who receive blood transfusions have higher incidents of heart attacks, heart failure, stroke and even death. “This is not a new issue. It has been a long struggle,” he said. While researchers had understood that banked blood is not the same as the blood in the body, the exact difference was not well understood.

“I think we have a good explanation and I think we have a solution,” Stamler said. He measured levels of nitric oxide in stored human blood obtained from a commercial supplier and found that the levels started dropping quickly. But if the nitric oxide was restored at any point, the red blood cells were again able to open blood vessels and deliver oxygen to tissues, he said. He tested the blood with added nitric oxide both in the lab and in dogs, and found the flow was restored.

Led by Dr Timothy McMahon, a second team at Duke University - whose study appears in the same journal - documented the depletion of nitric oxide in banked blood. “We were surprised at how quickly the blood changes,” he said. “We saw clear indications of nitric oxide depletion within three hours.” Both researchers called for clinical trials to study exactly who might benefit from banked blood.

They said researchers should study ways to safely add nitric oxide back into banked blood to see how this might improve its effectiveness. “In principle, we now have a solution to the nitric oxide problem. But it needs to be proven in a clinical trial,” Stamler said.

Posted in , |

Subscribe to: Posts (Atom)